177 related articles for article (PubMed ID: 38786034)
1. Phosphoproteomics Reveals Selective Regulation of Signaling Pathways by Lysophosphatidic Acid Species in Macrophages.
Dietze R; Szymanski W; Ojasalu K; Finkernagel F; Nist A; Stiewe T; Graumann J; Müller R
Cells; 2024 May; 13(10):. PubMed ID: 38786034
[TBL] [Abstract][Full Text] [Related]
2. An integrated phosphoproteomics work flow reveals extensive network regulation in early lysophosphatidic acid signaling.
Schreiber TB; Mäusbacher N; Kéri G; Cox J; Daub H
Mol Cell Proteomics; 2010 Jun; 9(6):1047-62. PubMed ID: 20071362
[TBL] [Abstract][Full Text] [Related]
3. Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment.
Reinartz S; Lieber S; Pesek J; Brandt DT; Asafova A; Finkernagel F; Watzer B; Nockher WA; Nist A; Stiewe T; Jansen JM; Wagner U; Konzer A; Graumann J; Grosse R; Worzfeld T; Müller-Brüsselbach S; Müller R
Mol Oncol; 2019 Feb; 13(2):185-201. PubMed ID: 30353652
[TBL] [Abstract][Full Text] [Related]
4. The lysophosphatidic acid-regulated signal transduction network in ovarian cancer cells and its role in actomyosin dynamics, cell migration and entosis.
Ojasalu K; Lieber S; Sokol AM; Nist A; Stiewe T; Bullwinkel I; Finkernagel F; Reinartz S; Müller-Brüsselbach S; Grosse R; Graumann J; Müller R
Theranostics; 2023; 13(6):1921-1948. PubMed ID: 37064875
[TBL] [Abstract][Full Text] [Related]
5. TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor.
Xu J; Lai YJ; Lin WC; Lin FT
J Biol Chem; 2004 Mar; 279(11):10459-68. PubMed ID: 14688263
[TBL] [Abstract][Full Text] [Related]
6. The Agpat4/LPA axis in colorectal cancer cells regulates antitumor responses via p38/p65 signaling in macrophages.
Zhang D; Shi R; Xiang W; Kang X; Tang B; Li C; Gao L; Zhang X; Zhang L; Dai R; Miao H
Signal Transduct Target Ther; 2020 Mar; 5(1):24. PubMed ID: 32296017
[TBL] [Abstract][Full Text] [Related]
7. Glycoprotein capture and quantitative phosphoproteomics indicate coordinated regulation of cell migration upon lysophosphatidic acid stimulation.
Mäusbacher N; Schreiber TB; Daub H
Mol Cell Proteomics; 2010 Nov; 9(11):2337-53. PubMed ID: 20639409
[TBL] [Abstract][Full Text] [Related]
8. Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific.
Baudhuin LM; Cristina KL; Lu J; Xu Y
Mol Pharmacol; 2002 Sep; 62(3):660-71. PubMed ID: 12181443
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidic acid induces focal adhesion assembly through Rho/Rho-associated kinase pathway in human ovarian cancer cells.
Sawada K; Morishige Ki; Tahara M; Ikebuchi Y; Kawagishi R; Tasaka K; Murata Y
Gynecol Oncol; 2002 Dec; 87(3):252-9. PubMed ID: 12468322
[TBL] [Abstract][Full Text] [Related]
10. Proteome-wide analysis of temporal phosphorylation dynamics in lysophosphatidic acid-induced signaling.
Mäusbacher N; Schreiber TB; Machatti M; Schaab C; Daub H
Proteomics; 2012 Dec; 12(23-24):3485-98. PubMed ID: 23090842
[TBL] [Abstract][Full Text] [Related]
11. Autotaxin-LPA axis regulates hMSC migration by adherent junction disruption and cytoskeletal rearrangement via LPAR1/3-dependent PKC/GSK3β/β-catenin and PKC/Rho GTPase pathways.
Ryu JM; Han HJ
Stem Cells; 2015 Mar; 33(3):819-32. PubMed ID: 25376707
[TBL] [Abstract][Full Text] [Related]
12. p85 beta-PIX is required for cell motility through phosphorylations of focal adhesion kinase and p38 MAP kinase.
Lee J; Jung ID; Chang WK; Park CG; Cho DY; Shin EY; Seo DW; Kim YK; Lee HW; Han JW; Lee HY
Exp Cell Res; 2005 Jul; 307(2):315-28. PubMed ID: 15893751
[TBL] [Abstract][Full Text] [Related]
13. Integrin α6β4 cooperates with LPA signaling to stimulate Rac through AKAP-Lbc-mediated RhoA activation.
O'Connor KL; Chen M; Towers LN
Am J Physiol Cell Physiol; 2012 Feb; 302(3):C605-14. PubMed ID: 22049212
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid stimulates cell growth by different mechanisms in SKOV-3 and Caov-3 ovarian cancer cells: distinct roles for Gi- and Rho-dependent pathways.
Hurst JH; Hooks SB
Pharmacology; 2009; 83(6):333-47. PubMed ID: 19420982
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid-mediated signal-transduction pathways involved in the induction of the early-response genes prostaglandin G/H synthase-2 and Egr-1: a critical role for the mitogen-activated protein kinase p38 and for Rho proteins.
Reiser CO; Lanz T; Hofmann F; Hofer G; Rupprecht HD; Goppelt-Struebe M
Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1107-14. PubMed ID: 9494074
[TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species mediate lysophosphatidic acid induced signaling in ovarian cancer cells.
Saunders JA; Rogers LC; Klomsiri C; Poole LB; Daniel LW
Free Radic Biol Med; 2010 Dec; 49(12):2058-67. PubMed ID: 20934509
[TBL] [Abstract][Full Text] [Related]
17. Unmasking of LPA1 receptor-mediated migration response to lysophosphatidic acid by interleukin-1β-induced attenuation of Rho signaling pathways in rat astrocytes.
Sato K; Horiuchi Y; Jin Y; Malchinkhuu E; Komachi M; Kondo T; Okajima F
J Neurochem; 2011 Apr; 117(1):164-74. PubMed ID: 21244430
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway.
Estrella VC; Eder AM; Liu S; Pustilnik TB; Tabassam FH; Claret FX; Gallick GE; Mills GB; Wiener JR
Int J Oncol; 2007 Aug; 31(2):441-9. PubMed ID: 17611702
[TBL] [Abstract][Full Text] [Related]
19. P2Y5 is a G(alpha)i, G(alpha)12/13 G protein-coupled receptor activated by lysophosphatidic acid that reduces intestinal cell adhesion.
Lee M; Choi S; Halldén G; Yo SJ; Schichnes D; Aponte GW
Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G641-54. PubMed ID: 19679818
[TBL] [Abstract][Full Text] [Related]
20. FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer.
Fan Q; Cai Q; Xu Y
Oncotarget; 2015 Sep; 6(29):27688-99. PubMed ID: 26299613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]